Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
102.00    0.20 (0.20%)
Bid:
102.40
Ask:
102.80
Spread: 0.40 (0.391%)
Market Cap: £167.22m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

12 May 2011 07:00

RNS Number : 4433G
Yule Catto & Co PLC
12 May 2011
 



12 May 2011

 

Yule Catto & Co plc (the "Group") 

 

Interim Management Statement

 

At this afternoon's AGM of Yule Catto & Co plc, the international producer of speciality chemicals, Chairman Peter Wood will make the following statement which also comprises the Group's interim management statement for the period 1 January 2011 to date.

 

The Group's earnings for the first quarter were well ahead of the same period last year excluding any impact of the PolymerLatex acquisition, and the Board's expectations for financial performance for 2011 remain unchanged.

 

Overall demand in Yule Catto's Polymer business was solid. Asian demand was strong through the quarter, whilst Europe firmed after a slow start in the UK. Ongoing very substantial monomer price increases have had to be passed on to customers, resulting in the usual temporary margin compression as the increases are recovered and target unit margins per tonne restored. Consequently, although volumes increased in Polymers and turnover was strongly ahead, operating profit was flat year on year in the first quarter. Whilst Europe lagged the prior year, Asia was ahead, despite, as expected, profits being temporarily constrained by capacity during the quarter. This position will be resolved in the course of the second quarter with the new 15,000 tonne nitrile expansion coming on line and some spare capacity in the acquired PolymerLatex nitrile assets. In April, the existing Yule Catto polymer business performed ahead of prior year.

 

The acquisition of PolymerLatex completed at the end of March as anticipated. Integration planning progressed through the first quarter and is now being implemented. Post acquisition, the synergy potential has been confirmed, and management remain highly confident that at least £20m of synergies will be delivered as disclosed at the time of the acquisition announcement and to the same timetable. Regular updates on progress in delivering these synergies will be provided to investors, with the first update to be delivered with the group's half year results in August. As at the date of this statement, actions taken to date have already delivered synergies with an annual run rate value of approximately £2m.

 

PolymerLatex itself traded comfortably ahead of last year in the first quarter, and this has continued through April. The business benefited from good demand in central Europe for latex and volume growth in its Malaysian nitrile facility. Plans are already being developed for very substantial increases in capacity in Asia for nitrile and SBR latex to be brought on line before the end of 2012.

 

In the Group's other businesses in the first quarter, the Pharma division performed well ahead of what was a very weak result in the same period last year, whilst William Blythe continued to grow profits strongly.

 

Net debt at the end of the quarter stood at £235m reflecting the impact of the acquisition of PolymerLatex, in line with the Group's forecasts at the time of the acquisition announcement.

 

- Ends -

 

ENQUIRIES:

 

Yule Catto & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief Executive

David Blackwood, Group Finance Director

MHP Communications

Tel: 020 3128 8100

Andrew Jaques

John Olsen

Ian Payne

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLFFLFERILLIL
Date   Source Headline
14th Oct 20133:55 pmRNSHolding(s) in Company
22nd Aug 201311:18 amRNSHolding(s) in Company
16th Aug 201312:36 pmRNSDirector/PDMR Shareholding
13th Aug 20137:00 amRNSInterim Results
12th Aug 20131:37 pmRNSHolding(s) in Company
7th Aug 20133:18 pmRNSHolding(s) in Company
4th Jul 20133:37 pmRNSHolding(s) in Company
28th Jun 20134:21 pmRNSHolding(s) in Company
6th Jun 201310:46 amRNSHolding(s) in Company
17th May 20134:33 pmRNSHolding(s) in Company
16th May 20131:07 pmRNSResult of AGM
16th May 20137:00 amRNSInterim Management Statement
2nd May 20134:59 pmRNSHolding(s) in Company
24th Apr 20134:37 pmRNSDirector/PDMR Shareholding
24th Apr 20134:36 pmRNSDirector/PDMR Shareholding
24th Apr 201311:14 amRNSHolding(s) in Company
16th Apr 201311:52 amRNSReplacement Annual Financial Report
16th Apr 20139:29 amRNSAnnual Financial Report
15th Apr 20131:58 pmRNSHolding(s) in Company
9th Apr 201311:52 amRNSDirector/PDMR Shareholding
28th Mar 20139:19 amRNSHolding(s) in Company
19th Mar 20134:31 pmRNSHolding(s) in Company
15th Mar 20137:00 amRNSPreliminary Results
14th Feb 20131:59 pmRNSReplacement Director Declaration
14th Feb 20131:00 pmRNSDirectorate Change
13th Feb 201311:23 amRNSHolding(s) in Company
7th Feb 201312:26 pmRNSDirectorate Change
1st Feb 20134:37 pmRNSDirector Declaration
19th Dec 201210:08 amRNSReplacement Holding(s) in Company
17th Dec 201210:11 amRNSDirector Declaration
14th Dec 201212:38 pmRNSReplacement Holding(s) in Company
14th Dec 201212:27 pmRNSDirector Declaration
6th Dec 20124:35 pmRNSHolding(s) in Company
4th Dec 201212:17 pmRNSResult of EGM
16th Nov 201211:34 amRNSDirector Declaration
8th Nov 20127:00 amRNSNotice of General Meeting
8th Nov 20127:00 amRNSInterim Management Statement
1st Nov 201212:28 pmRNSHolding(s) in Company
12th Oct 20124:15 pmRNSHolding(s) in Company
5th Oct 20127:00 amRNSDirectorate Change
27th Sep 20122:24 pmRNSHolding(s) in Company
25th Sep 20124:06 pmRNSHolding(s) in Company
10th Sep 20123:38 pmRNSDirector Declaration
6th Sep 20128:58 amRNSHolding(s) in Company
28th Aug 20127:00 amRNSInterim Results 2012
22nd Aug 20125:06 pmRNSHolding(s) in Company
13th Aug 20124:32 pmRNSHolding(s) in Company
24th Jul 201210:23 amRNSHolding(s) in Company
20th Jul 20124:10 pmRNSHolding(s) in Company
16th Jul 20129:33 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.